Get Your Personalized Supplement StackSupplement Stack Quiz

Beta 1,3/1,6-D-Glucan 85%

Also known as: Beta-(1,3/1,6)-D-glucan, β-(1,3/1,6)-D-glucan, Beta glucan, β-glucan, yeast beta glucan, mushroom beta glucan

Overview

Beta-(1,3/1,6)-D-glucan is a polysaccharide found in the cell walls of yeast, fungi (such as Pleurotus ostreatus), and some cereals. It is widely used as a supplement for immune support. As an immunomodulatory polysaccharide, it is primarily used for immune modulation, prevention of upper respiratory tract infections, and metabolic health support. Key characteristics include its high molecular weight and water solubility (or insolubility, depending on the source). It is recognized for its immune-stimulating properties. Research maturity is moderate, with several RCTs and systematic reviews available, though more large-scale, long-term studies are needed. The quality of available evidence is good for immune effects in healthy adults, moderate for metabolic effects, and limited for long-term safety and efficacy in chronic disease.

Benefits

Systematic reviews and meta-analyses indicate that beta glucan supplementation can reduce the incidence of upper respiratory tract infections (URTIs) in healthy adults. Effect sizes are modest but statistically significant, with some studies reporting a reduction in URTI incidence by up to 25% compared to placebo. Emerging evidence suggests benefits in metabolic health, including improved glycemic control (reduction in HbA1c) and favorable effects on lipid profiles, though these findings are preliminary and require further validation. Most robust evidence is in healthy adults; limited data in children, elderly, or immunocompromised populations. For immune support, effect sizes are small to moderate.

How it works

Beta glucans are recognized by pattern recognition receptors (e.g., Dectin-1) on immune cells, leading to activation of innate immunity, enhanced phagocytosis, and cytokine production. It primarily interacts with the immune system and may also influence metabolic pathways via anti-inflammatory and anti-glycemic effects. Known molecular targets include the Dectin-1 receptor, complement system, macrophages, and dendritic cells. Oral bioavailability is limited due to high molecular weight; most effects are mediated via gut-associated lymphoid tissue (GALT) and systemic immune modulation.

Side effects

Beta-(1,3/1,6)-D-glucan is generally recognized as safe (GRAS) in healthy adults at recommended doses. Common side effects are rare, with occasional mild gastrointestinal discomfort reported. Uncommon side effects are very rare, with no consistent reports in the literature. Rare side effects include allergic reactions possible in sensitive individuals. No significant drug interactions have been reported, but there is a theoretical risk of immune overstimulation in immunocompromised individuals. It is contraindicated in individuals with known hypersensitivity to beta glucans or fungal/yeast products. Limited data exists in pregnancy, lactation, and children, so use with caution in immunocompromised individuals.

Dosage

The minimum effective dose is 100–250 mg/day for immune support (based on yeast-derived beta glucan). Optimal dosage ranges are 250–500 mg/day for most adults; higher doses (up to 1,000 mg/day) have been used in some studies without increased adverse effects. The maximum safe dose is not well established, but doses up to 1,000 mg/day appear safe in short-term studies. It can be taken with or without food, as timing does not significantly affect efficacy. Yeast-derived and mushroom-derived beta glucans are most studied; ensure product purity and standardization (e.g., 85% beta glucan content). Absorption is limited; effects are primarily mediated via the gut immune system.

FAQs

How should I take beta glucan?

Beta glucan is generally well tolerated. Start with the lower end of the dose range (250mg) and monitor for gastrointestinal symptoms. Consistency is more important than timing; it can be taken at any time of day, with or without food.

Is beta glucan safe?

No evidence of toxicity at recommended doses exists. However, it should be avoided in individuals with known hypersensitivity to beta glucans or fungal/yeast products, and those with severe immune disorders should consult their healthcare provider.

What results can I expect from taking beta glucan?

You can expect a modest reduction in upper respiratory tract infection (URTI) incidence. Possible metabolic benefits may be observed with longer-term use. It is not a cure-all; effects are most robust for immune support in healthy adults.

What is beta glucan?

Beta glucan is a polysaccharide derived from sources like yeast, fungi, and cereals. It's known for its immunomodulatory properties, meaning it can help regulate and support the immune system.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9619242/ – This systematic review and meta-analysis of multiple RCTs involving healthy adults found that beta glucan supplementation reduced the incidence of upper respiratory tract infections by up to 25% compared to placebo. The review highlights heterogeneity in study designs and beta glucan sources and notes the limited availability of long-term data.
https://www.medrxiv.org/content/10.1101/2021.08.05.21261640v1.full.pdf – This preclinical and clinical study (preprint, not peer-reviewed) with four groups (n≥30 per group) found that beta glucan (N-163 strain) improved glycemic control (reduced HbA1c) and lipid profiles, with anti-inflammatory and immunomodulatory effects. The study is limited by its preprint status, short duration, and small sample size, requiring peer-reviewed validation.
https://pubmed.ncbi.nlm.nih.gov/25081986/ – This study investigates the role of serum 1,3-β-D-glucan as a diagnostic marker for invasive fungal infections. While not directly related to beta-glucan supplementation, it highlights the compound's clinical relevance in identifying fungal infections.
https://www.sciencedirect.com/science/article/pii/S1684118214001200 – This study investigates the role of serum 1,3-β-D-glucan as a diagnostic marker for invasive fungal infections. While not directly related to beta-glucan supplementation, it highlights the compound's clinical relevance in identifying fungal infections.
https://journals.asm.org/doi/10.1128/jcm.03276-20 – This study investigates the role of serum 1,3-β-D-glucan as a diagnostic marker for invasive fungal infections. While not directly related to beta-glucan supplementation, it highlights the compound's clinical relevance in identifying fungal infections.